We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Agilent Expands Life Science Disease Research Portfolio with Eurofins MWG Operon Asset Purchase

News   Nov 17, 2009

 
Agilent Expands Life Science Disease Research Portfolio with Eurofins MWG Operon Asset Purchase
 
 
Advertisement
 

RELATED ARTICLES

Evidence for a DNA Methylation Signature of ASD in Cord Blood

News

A new study led by UC Davis MIND Institute researchers found a distinct DNA methylation signature in the cord blood of newborns who were eventually diagnosed with autism spectrum disorder (ASD). This signature mark spanned DNA regions and genes linked to early fetal neurodevelopment. The findings may hold clues for early diagnosis and intervention.

READ MORE

Like a Stamped Passport, SARS-Cov-2 Mutations Tell a Tale of Its Transmission in the US

News

The coronavirus, responsible for the COVID-19 pandemic, has one official name—SARS-CoV-2. But according to virologists, mutations lead to hundreds of genetically-distinct versions of the virus. Scientists at Children’s Hospital Los Angeles have used these viral signatures to reveal transmission patterns, which show the effectiveness of early safety measure policies.

READ MORE

Ancient DNA Elements Can Activate a Powerful Immune Response to Cancer Cells

News

Ancient embedded elements in our DNA from generations past can activate a powerful immune response to kill cancer cells like an infection.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE